doxycycline hyclate 50 MG Delayed Release Oral Tablet
- RxCUI
- 1653433
- RxNorm name
- doxycycline hyclate 50 MG Delayed Release Oral Tablet
- Display name
- Doxycycline (Oral Pill)
- Full name
- doxycycline hyclate 50 MG Delayed Release Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 50 mg
- Dose form
- DR Tab
- Route
- Oral Pill
- Updated
- 2026-11-12 18:37:15
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072015
- Active start
- 072015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline hyclate | 50 MG / 1 EACH | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Delayed Release Oral Tablet | 10312 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | doxycycline hyclate 50 MG Delayed Release Oral Tablet | 1 | NAMES |
| RxNorm Name | doxycycline hyclate 50 MG Delayed Release Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1653433 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0591-4550-22 | 0591-4550 | Doxycycline Hyclate Doxycycline Hyclate | Actavis Pharma, Inc. | ANDA090134 |
| 43547-462-12 | 43547-462 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | ANDA207494 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA090134 | 0591-4550 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | Actavis Pharma, Inc. |
| ANDA207494 | 43547-462 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | ANDA | Solco Healthcare US LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | 2025-10-31 | Warnings, Adverse reactions | 43547-462-12 43547-462 43547046212 1653433 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | c2b08332-3256-4658-965a-ede3d973a388 | 2025-04-01 | Warnings, Adverse reactions | 0591-4550-22 0591-4550 00591455022 1653433 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c2b08332-3256-4658-965a-ede3d973a388 | doxycycline hyclate 50 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 50 MG Delayed Release Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | 20250401 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | doxycycline hyclate 50 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 50 MG Delayed Release Oral Tablet [SCD] | 2 | 7 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | 20251031 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20251031 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20251031 |
| f9c63af9-d613-43fc-b8e5-ab6219f24c70 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Mayne Pharma Commercial LLC | Mayne Pharma International Pty Ltd | Catalent Greenville, Inc. | 20250414 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| c2b08332-3256-4658-965a-ede3d973a388 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Actavis Pharma, Inc. | 20250401 |
| 0a18d4c7-9484-4d3e-b61b-e81fe63fefec | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd. | 20220922 |
| 0c01acd6-123b-43f3-b639-b039e83baa27 | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS . DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967 | Mylan Pharmaceuticals Inc. | 20200226 |
| 2e9d34a2-8173-4202-8187-3994bd8a9e1d | These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967 | Mylan Pharmaceuticals Inc. | 20170130 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline hyclate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline hyclate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 50 MG (expressed as doxycycline hyclate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA090134 |
| CODES | ANDA | ANDA207494 |
| CODES | VUID | 4034510 |
| NAMES | Prescribable Synonym | doxycycline hyclate 50 MG Delayed Release Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |